{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:22:10Z","timestamp":1767374530356,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.clinbiochem.2004.12.002","type":"journal-article","created":{"date-parts":[[2005,1,25]],"date-time":"2005-01-25T23:15:39Z","timestamp":1106694939000},"page":"223-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN)"],"prefix":"10.1016","volume":"38","author":[{"given":"Srebrena Y.","family":"Atanasova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"von Ahsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Draga I.","family":"Toncheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzvetan G.","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Oellerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2004.12.002_bib1","series-title":"Endemic (Balkan) nephropathy","first-page":"7","article-title":"Clinical investigations in patients with endemic nephropathy","author":"Puchlev","year":"1979"},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/qjmed\/91.7.457","article-title":"Balkan endemic nephropathy: a need for novel aetiological approaches","volume":"91","author":"Stefanovic","year":"1998","journal-title":"Q. J. Med."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib3","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1016\/S0166-5162(98)00071-8","article-title":"A possible link between Balkan endemic nephropathy and the leaching of toxic organic compounds from Pliocene lignites by groundwater","volume":"40","author":"Orem","year":"1999","journal-title":"Int. J. Coal Geol."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1023\/A:1007445120729","article-title":"Etiology of Balkan Endemic Nephropathy: a multifactorial disease","volume":"14","author":"Toncheva","year":"1998","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/dna.1996.15.273","article-title":"Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer","volume":"15","author":"Nebert","year":"1996","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/03602539709037591","article-title":"Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors","volume":"29","author":"Rendic","year":"1997","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/clinchem\/44.5.914","article-title":"Ultrarapid drug metabolism: PCR-based detection of CYP2D6 gene duplication","volume":"44","author":"Steijns","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib8","first-page":"289","article-title":"Genetic predisposition to Balkan endemic nephropathy: ability to hydroxylate debrisoquine as a host risk factor","volume":"115","author":"Nikolov","year":"1991","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0026-895X(25)09155-2","article-title":"Bimodal distribution of renal cytochrome P450 3A activity in humans","volume":"50","author":"Haehner","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/jnci\/90.16.1225","article-title":"Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4","volume":"90","author":"Rebbeck","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib11","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/clinchem\/47.6.1048","article-title":"No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients","volume":"47","author":"von Ahsen","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00008571-200112000-00005","article-title":"The genetic determinants of the CYP3A5 polymorphism","volume":"11","author":"Hustert","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib14","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1152\/japplphysiol.00322.2003","article-title":"Cyp3a5 genotype predicts renal Cyp3a activity and blood pressure in healthy adults","volume":"95","author":"Givens","year":"2003","journal-title":"J. Appl. Physiol."},{"issue":"Suppl. 6","key":"10.1016\/j.clinbiochem.2004.12.002_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ndt\/16.suppl_6.27","article-title":"Open questions on Balkan nephropathy","volume":"16","author":"Djukanovic","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0140-6736(90)92086-W","article-title":"Genotyping of poor metabolizers of debrisoquine by allelle-specific PCR amplification","volume":"336","author":"Heim","year":"1990","journal-title":"Lancet"},{"year":"1999","series-title":"Computer programs for epidemiologists: PEPI version 3","author":"Abramson","key":"10.1016\/j.clinbiochem.2004.12.002_bib17"},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib18","first-page":"284","article-title":"Cytochrome P450 2D6 variants in Caucasian population: allele frequencies and phenotypic consequences","volume":"60","author":"Sachse","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/clpt.1992.2","article-title":"Analysis of the CYP2D6 gene in relation to debrisoquine and desipramine hydroxylation in a Swedish population","volume":"51","author":"Dahl","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00008571-200102000-00006","article-title":"Polymorphisms in CYP2D6 duplication\u2014negative individuals with ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?","volume":"11","author":"Lovlie","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib21","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1124\/dmd.30.10.1108","article-title":"Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA","volume":"30","author":"Koch","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00210-003-0815-3","article-title":"Cytochrome P450 3A and their regulation","volume":"369","author":"Burk","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2125.1988.tb03331.x","article-title":"The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extra-hepatic tissues with a monoclonal antibody to human cytochrome P-450","volume":"25","author":"Murray","year":"1988","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2004.12.002_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/toxsci\/59.1.59","article-title":"Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites?","volume":"59","author":"Zepnik","year":"2001","journal-title":"Toxicol. Sci."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991200400339X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991200400339X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:22:08Z","timestamp":1757863328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991200400339X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S000991200400339X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.12.002","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN)","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}